| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039488 Salt of naphthyridine carboxylic acid derivative |
| 02/14/2008 | US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression |
| 02/14/2008 | US20080039373 Pegylated Factor VII Glycoforms |
| 02/14/2008 | US20080038374 New Use |
| 02/14/2008 | US20080038240 Using bacillus coagulans inoculation to increase carbohydrate absorption in mammals and reduce symptoms of gastrointestinal distress |
| 02/14/2008 | US20080038238 Human Stem Cell Materials and Methods |
| 02/14/2008 | US20080038222 Composition Comprising Colony Stimulating Factor for Treatment of a Localised Bacterial Infection and Bacterial Related Disease |
| 02/13/2008 | EP1886994A1 Cyclic amine compounds as CCR5 antagonists |
| 02/13/2008 | EP1572220B1 Antiviral properties of extracts of dichrostachys glomerata |
| 02/13/2008 | EP1517679B1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 02/13/2008 | EP0758244B2 Controlled-release dosage forms of azithromycin |
| 02/13/2008 | CN101123993A Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 02/13/2008 | CN101123878A L-threonine derivatives of high therapeutic index |
| 02/13/2008 | CN101123871A Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 02/13/2008 | CN101120935A Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 02/13/2008 | CN101120934A Compositions for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with menthylphenidate |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100367965C Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 02/12/2008 | US7329746 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/12/2008 | US7329678 Benzimidazolyl-pyridine derivatives; Serum and Glucocorticoid-Regulated Kinase 1 inhibitors; 3-(1H-benzimidazol-2-yl)-5-phenylpyridin-2-amine; regulation of electrolyte balance in renal and cardiovascular disease, antiproliferative agents, rheumatoid arthritis, psoriasis, septic shock, bone loss |
| 02/12/2008 | US7329668 For therapy of inflammatory diseases, immune diseases, and cancer |
| 02/12/2008 | US7329641 Blood substitutes |
| 02/12/2008 | US7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor |
| 02/12/2008 | US7329498 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080032417 Photocleavable isotope-coded affinity tags |
| 02/07/2008 | US20080031897 Prevention of allergy in children |
| 02/06/2008 | EP1884247A2 Gastrin compositions and formulations, and methods of use and preparation |
| 02/06/2008 | EP1682076A4 Inhibitors of coronavirus protease and methods of use thereof |
| 02/06/2008 | CN101116746A Prevention and treatment of amyloidogenic disease |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
| 02/05/2008 | US7326706 Pyrazine modulators of cannabinoid receptors |
| 02/05/2008 | US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example |
| 02/05/2008 | US7326687 CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | CA2313618C Transmucosal formulations of levosimendan |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080026042 Preoperative Treatment of Post Operative Pain |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025963 Compositions and methods for the treatment of CNS injuries |
| 01/31/2008 | US20080025913 Novel Anti-Dc-Sign Antibodies |
| 01/30/2008 | CN101115472A Molecules enhancing dermal delivery of influenza vaccines |
| 01/30/2008 | CN101113450A Neurotrophic factor |
| 01/30/2008 | CN101113449A Neurotrophic factor |
| 01/30/2008 | CN101112616A Vaccine for the prophylactic or therapeutic immunization against HIV |
| 01/30/2008 | CN100364534C Use of n-substituted-1,5-di deoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
| 01/29/2008 | US7323552 Genetic engineering; diagnosis of antiinflammatory agents |
| 01/29/2008 | US7323495 Synthetic lactone formulations and method of use |
| 01/29/2008 | US7323482 Therapy of p38 kinase-associated conditions; may be useful in treating inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 01/29/2008 | US7323334 Using prokineticin receptor as diagnostic screening tool to identify modulators of nervous system development; treating neurodegenerative disorders |
| 01/29/2008 | US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 01/29/2008 | US7323119 by using phosphite compounds containing the bis-cyclic structure of spiro phosphites, both rings being attached to the same tertiary carbon atom in the phosphite molecule; protect against discoloration for prolonged usage |
| 01/29/2008 | CA2311128C Composition with azelaic acid |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2285985C A method for preparing aqueous liposomal compositions comprising an active ingredient which is highly insoluble in water |
| 01/29/2008 | CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 01/24/2008 | WO2004103299A3 Compositions and methods for the treatment of cns injuries |
| 01/24/2008 | WO2004069206A3 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/24/2008 | US20080021046 USE OF 8-SUBSTITUTED-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080019955 Surface Protection of Exposed Biological Tissues |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1633354B1 N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes |
| 01/23/2008 | EP1446117A4 Treatment of acute myeloid leukemia with indolinone compounds |
| 01/23/2008 | CN101111226A Medical product for inhalation containing glucagon-like peptide-1 (glp-1) |
| 01/23/2008 | CN100363393C Anionic vinyl/dicarboxylic acid polymers and uses thereof |
| 01/22/2008 | US7321065 E.g., N-methyl-O-benzyl-tyramine, 3,5,3',5'-tetraiodothyroethanolamine; antagonist of a G protein coupled receptor and a trace amine receptor; antidepressants; nervous system disorders; antidiabetic agents; antiarrhymia disorders; glandular disorders of the thyroid; congestive heart failure; analgesics |
| 01/22/2008 | US7320806 Purified malted barley extract is administered for activating adenosine 5'-monophosphate-activated protein kinase |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/17/2008 | WO2004100899A3 Use of secretin in treatments of disorders associated with the amygdala |
| 01/17/2008 | US20080015254 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/17/2008 | US20080015215 Diamine derivatives |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080014594 Lung-Expressed Polypeptides |
| 01/17/2008 | DE4215677B4 Pharmazeutisches Mittel The pharmaceutical agent |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1635853A4 Topical composition for the treatment of skin disorders and methods of using the same |
| 01/16/2008 | EP1599231A4 Treatment of pain through expression of opioid receptors |
| 01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 01/16/2008 | EP1091753B1 Antiproliferative and antiviral proteins and peptides |
| 01/16/2008 | CN101107003A Homeopathic formulations useful for treating pain and/or inflammation |
| 01/16/2008 | CN100362010C Mevalonic acid derivative |
| 01/15/2008 | US7319170 Hyperglycemia that is symptomatic of type II diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, and obesity that are often associated with type 2 diabetes; N-[(cyclohexylamino)carbonyl]-4-{3-[4-(4-fluorophenoxy)-2-propylphenoxy]propoxy}benzenesulfonamide |
| 01/15/2008 | US7319111 Phenylenediamine Urotensin-II receptor antagonists and CCR-9 antagonists |
| 01/15/2008 | US7318938 Plant extract; cognition activators |
| 01/10/2008 | US20080009472 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/10/2008 | US20080008690 AAV virions with decreased immunoreactivity and uses therefor |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives |
| 01/09/2008 | EP1874277A1 Sustained release l-arginine formulations and methods of manufacture and use |
| 01/09/2008 | EP1684706A4 Genes differentially expressed by acutely isolated resident progenitor cells of the human white matter |
| 01/09/2008 | EP1663262A4 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 01/09/2008 | EP1610760A4 Topical l-carnitine compositions |
| 01/09/2008 | EP0814789B2 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/09/2008 | CN101102770A Amelioration of cataracts, macular degeneration and other ophthalmic diseases |